Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Sarcoidosis and Crohn disease are chronic granulomatous conditions of unknown pathogenesis that affect multiple organ systems. A common mechanism has been proposed but never proved. Recently, it has been suggested that human herpesvirus 8 (HHV-8) might play a role in the pathogenesis of sarcoidosis based on polymerase chain reaction studies showing HHV-8 in a high proportion of affected tissues.1 We used polymerase chain reaction studies to amplify a 233–base pair fragment of HHV-8 DNA in archived specimens of tissues from patients with sarcoidosis and Crohn disease who had never been treated with corticosteroids or immunomodulator agents to determine if HHV-8 might be present in these tissues.
Archived tissue specimens from the skin of 8 patients with sarcoidosis and from the small bowel of 7 patients with Crohn disease were selected on the basis of clinical history and histopathologic findings, including the presence of granulomas. Three Kaposi sarcoma specimens and 1 primary effusion lymphoma specimen were selected as positive control tissues, and negative controls included cutaneous squamous cell carcinomas and reexcisions of normal skin from patients with dysplastic nevi.
Two pathologists (J.W.P. and M.H.S.) independently confirmed the histopathologic diagnoses. We performed tissue preparation, polymerase chain reaction, and gel fractionation on all specimens according to the method described by Gaffey et al.2 We used 50 amplification cycles. Human herpesvirus 8 DNA was not detected in affected tissues of patients with either sarcoidosis or Crohn disease. We detected HHV-8 DNA in the control samples of Kaposi sarcoma and primary effusion lymphoma but not in samples of squamous cell carcinoma or normal skin (Figure). We successfully amplified β-globulin in the Crohn disease and sarcoidosis specimens, which indicates that these specimens contained amplifiable DNA and lacked polymerase chain reaction inhibitors.
Representative gel fractionation product from polymerase chain reaction amplification of a 233–base pair fragment of human herpesvirus 8 (HHV-8) DNA from various tissues. Lanes 1 and 26 are 100–pair size ladders; even lanes 2 through 24, and β-globulin amplifications; odd lanes 3 through 25, HHV-8 DNA amplifications. Lanes 22 and 23 are normal skin controls; 24 and 25, no DNA negative controls. Lanes 2 and 3 are colonic Crohn disease; 4 and 5, ileal Crohn disease; 6 and 7, mediastinal sarcoidosis; 8 and 9, cutaneous sarcoidosis; 10 through 15, cutaneous squamous cell carcinoma (1 of which failed to amplify); 16 through 19, cutaneous Kaposi sarcoma; and 20 and 21, pleural effusion lymphoma.
Human herpesvirus 8 is a novel member of the γ-herpesvirus subfamily that has been implicated in the pathogenesis of Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.1 The mechanism of HHV-8 in the induction and perpetuation of disease is not well understood; however, HHV-8 genetic homologues to human oncogenes and intercellular regulatory molecules may play a role in the pathogenesis of diseases related to the virus.
Although the cause of these granulomatous disorders has not yet been determined, it has been suspected that sarcoidosis and Crohn disease might share a common etiology based on clinical and pathologic similarities. Histologically, the 2 disorders can be virtually indistinguishable. Both diseases share common aberrations in the immune system, including altered numbers and responsiveness of T cells and dysregulation of various cytokines. Elevated serum levels of angiotensin converting enzyme are observed in the acute phase of both conditions.3
Our results argue against HHV-8 as an etiologic factor in sarcoidosis and Crohn disease. This supports findings of other investigators who have been unable to link HHV-8 infection with sarcoidosis.4 - 5 Although Di Alberti et al1 did detect HHV-8 in archived sarcoidosis tissues using a polymerase chain reaction method similar to ours, the reasons for the discrepancy are not entirely clear. In future investigations, confirmation by in situ hybridization or control for regional prevalence of HHV-8 may be helpful.
Correspondence: Dr Patterson, Department of Pathology, University of Virginia, PO Box 800214, Charlottesville, VA 22908 (jwp9e@virginia.edu).
Financial Disclosure: None.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.